Apyx Medical Corporation (APYX) News
Filter APYX News Items
APYX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest APYX News From Around the Web
Below are the latest news stories about APYX MEDICAL CORP that investors may wish to consider to help them evaluate APYX as an investment opportunity.
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial OfficerCLEARWATER, Fla., November 28, 2023--Apyx Medical Corporation (Nasdaq:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced the appointment of Matthew Hill to the position of Chief Financial Officer, effective December 4, 2023. Mr. Hill succeeds Tara Semb, whose departure was announced by the Company on November 9, 2023. |
Apyx Medical Corporation (NASDAQ:APYX) Q3 2023 Earnings Call TranscriptApyx Medical Corporation (NASDAQ:APYX) Q3 2023 Earnings Call Transcript November 9, 2023 Apyx Medical Corporation misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.1. Operator: Please stand by. Hello, and welcome, ladies and gentlemen, to the Third Quarter of Fiscal Year 2023 Earnings Conference Call for Apyx Medical Corporation. At this time, […] |
Apyx Medical Corp (APYX) Reports 31% Revenue Growth in Q3; Updates Full Year OutlookAdvanced Energy Sales Surge as Company Adjusts Annual Guidance |
Apyx Medical Corporation Announces New Debt Facility with Perceptive AdvisorsCLEARWATER, Fla., November 09, 2023--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that the Company and its subsidiaries have entered into a new, five-year credit agreement with Perceptive Credit Holdings IV, LP ("Perceptive"), an affiliate of Perceptive Advisors. The Perceptive Credit Agreement provides for a facility of up to $45 million in senior secured term |
Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial OutlookCLEARWATER, Fla., November 09, 2023--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported financial results for its third quarter ended September 30, 2023, and updated its financial expectations for the full year ending December 31, 2023. |
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in NovemberCLEARWATER, Fla., November 07, 2023--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, announced today that management will participate in the following upcoming investor conferences: |
Are Medical Stocks Lagging Apyx Medical (APYX) This Year?Here is how Apyx Medical (APYX) and CymaBay Therapeutics Inc. (CBAY) have performed compared to their sector so far this year. |
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023CLEARWATER, Fla., October 02, 2023--Apyx® Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the third quarter of fiscal year 2023 will be released before the market opens on Thursday, November 9th. |
Apyx Medical Corporation (NASDAQ:APYX) Q2 2023 Earnings Call TranscriptApyx Medical Corporation (NASDAQ:APYX) Q2 2023 Earnings Call Transcript August 12, 2023 Operator: Hello, and welcome, ladies and gentlemen, to the Second Quarter of Fiscal 2023 Earnings Conference Call for Apyx Medical Corporation. At this time, all participants have been placed in a listen-only mode. At the end of the company’s prepared remarks, we will […] |
Q2 2023 Apyx Medical Corp Earnings CallQ2 2023 Apyx Medical Corp Earnings Call |